-
公开(公告)号：KR1020100097648A
公开(公告)日：2010-09-03
申请号：KR1020100080997
申请日：2010-08-20
Applicant: (주)아모레퍼시픽
IPC: A61K36/254 , A61K36/74 , A61P17/00
Abstract: PURPOSE: An external use skin composition containing herb extract is provided to suppress T lymphocyte-mediated immune reaction and to prevent or treat atopic dermatitis, contact dermatitis, and psoriasis. CONSTITUTION: A cosmetic composition for treating T lymphocyte-mediated dermal immune diseases contains 0.001-10 weight% of Thujae Semen extract as an active ingredient. A method for producing the Thujae Semen extract comprises: a step of pulverizing Thujae Semen and adding 95% of ethanol; a step of heating at 80°C for 2 hours to extract active ingredient; a precipitating impurities and filtering; and a step of evaporating. A pharmaceutical composition for treating T lymphocyte-mediated dermal immune diseases contains Thujae Semen extract as an active ingredient.
Abstract translation: 目的：提供含有草药提取物的外用皮肤组合物，以抑制T淋巴细胞介导的免疫反应，预防或治疗特应性皮炎，接触性皮炎和牛皮癣。 构成：用于治疗T淋巴细胞介导的真皮免疫疾病的化妆品组合物含有0.001-10重量％的Thujae Semen提取物作为活性成分。 一种Thujae Semen提取物的制造方法，其特征在于，包括：将Thujae Semen粉碎并加入95％乙醇的步骤; 在80℃下加热2小时以提取活性成分的步骤; 沉淀杂质和过滤; 和蒸发的步骤。 用于治疗T淋巴细胞介导的真皮免疫疾病的药物组合物含有Thujae Semen提取物作为活性成分。
-
公开(公告)号：KR1020100031117A
公开(公告)日：2010-03-19
申请号：KR1020100011764
申请日：2010-02-09
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition of a skin external agent is provided to treat and prevent various dermatitis caused by T lymphocyte-mediated immune response. CONSTITUTION: A cosmetic composition for relieving dermatitis caused by T lymphocyte-mediated immune response contains Dalbergiae odoriferae lignum extract as an active ingredient. The dermatitis includes atopic dermatitis, contact dermatitis or psoriasis. The composition contains 0.001-10 weight% of Dalbergiae odoriferae lignum extract based on total weight.
Abstract translation: 目的：提供皮肤外用剂的组合物，以治疗和预防由T淋巴细胞介导的免疫应答引起的各种皮炎。 构成：用于缓解由T淋巴细胞介导的免疫应答引起的皮炎的化妆品组合物含有檀香木提取物作为活性成分。 皮炎包括特应性皮炎，接触性皮炎或牛皮癣。 该组合物含有0.001-10重量％的总重量的檀香木提取物。
-
公开(公告)号：KR1020100021641A
公开(公告)日：2010-02-25
申请号：KR1020100011765
申请日：2010-02-09
Applicant: (주)아모레퍼시픽
IPC: A61K36/14 , A61K36/254 , A61K36/74 , A61P17/00
Abstract: PURPOSE: A skin external composition containing herb extract is provided to suppress T lymphocyte-mediated immune reaction and treat or prevent dermatitis such as atopic dermatitis, contact dermatitis and prsoriasis. CONSTITUTION: A cosmetic composition for treating T-lymphocyte-mediated dermatitis contains 0.001-10 weight% of Thujae Semen extract as an active ingredient. The cosmetic composition is used in the form of massage cream, moisturizing cream, pack, gel, essence, lotion, ointment, gel, cream, or patch.
Abstract translation: 目的：提供含有草本提取物的皮肤外用组合物，以抑制T淋巴细胞介导的免疫反应，治疗或预防皮炎如特应性皮炎，接触性皮炎和牛皮癣。 构成：用于治疗T淋巴细胞介导的皮炎的化妆品组合物含有0.001-10重量％的Thujae Semen提取物作为活性成分。 化妆品组合物以按摩霜，保湿霜，包装，凝胶，精华液，洗剂，软膏，凝胶，霜或贴剂的形式使用。
-
公开(公告)号：KR1020090115705A
公开(公告)日：2009-11-05
申请号：KR1020090101103
申请日：2009-10-23
Applicant: (주)아모레퍼시픽
IPC: A61K36/185 , A61P17/06 , A61P17/00
Abstract: PURPOSE: A skin external composition containing medicinal herb extract is provided to ensure high suppression activity of immune reaction and prevent and treat dermatitis such as atopic dermatitis, contact dermatitis, and psoriasis. CONSTITUTION: A skin external composition for preventing or treating atopic dermatitis, contact dermatitis, or psoriasis contains medicinal herb extract as an active ingredient. The medicinal herb contains Asiasari Radix, Perillae Herba, Perillae Semen, Cimicifugae Rhizoma, Melandrii Herba, Solani Nigri Herba, Arctii Semen, Potentillae Radix, Cinnamomi Cortex Spissus, Hoelen rubra, Phaseoli angularis Semen, Fagopyrum esculentum, or Chenopodium album var. centrorubrum.
Abstract translation: 目的：提供含有药草提取物的皮肤外用组合物，以确保免疫反应的高度抑制活性，预防和治疗皮炎如特应性皮炎，接触性皮炎和牛皮癣。 构成：用于预防或治疗特应性皮炎，接触性皮炎或牛皮癣的皮肤外用组合物含有草药提取物作为活性成分。 药用草药含有Asiasari Radix，Perillae Herba，Perillae Semen，Cimicifugae Rhizoma，Melandrii Herba，Solani Nigri Herba，Arctii Semen，Potentillae Radix，Cinnamomi Cortex Spissus，Hoelen rubra，Phaseoli angularis Semen，Fagopyrum esculentum或Chenopodium album var。 centrorubrum。
-
公开(公告)号：KR1020070032520A
公开(公告)日：2007-03-22
申请号：KR1020050086828
申请日：2005-09-16
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61Q19/007 , A61Q19/008
Abstract: A skin external composition containing the extracts of Korean medicinal flowers is provided to express bright skin by covering pigmentation on the skin, maintain moisturizing effects for a long period of time, and improve wrinkle and elasticity of the skin. The skin external composition contains the extracts of at least one Korean medicinal flower selected from Althea rosea, Chrysanthemum morifolium, Prunus persica, Rosa rugosa and Nelumbo nucifera, wherein the amount of Korean medicinal flower extracts is 0.0001-10 wt.% based on the total weight of the composition. The extracts of Korean medicinal flowers are prepared by independently extracting Korean medicinal flowers with 70% ethanol at room temperature for 48 hours, filtering the extract with filter paper, and concentrating the filtered solution at 50 deg.C under reduced pressure.
Abstract translation: 提供含有韩国药用植物提取物的皮肤外用组合物，通过覆盖皮肤上的色素沉着，长时间保持保湿效果，并改善皮肤的皱纹和弹性来表现明亮的皮肤。 皮肤外用组合物含有至少一种韩国药用植物提取物，其选自蔷薇，菊花，桃李，罗莎和Nelumbo nucifera，其中韩国药用花提取物的量为总重量的0.0001-10重量％ 组合物的重量。 韩国药用植物提取物通过在室温下独立地提取70％乙醇的韩国药用植物油48小时，用滤纸过滤提取物，并在50℃减压浓缩滤液。
-
Patent Agency Ranking
公开(公告)号：KR1020070028902A
公开(公告)日：2007-03-13
申请号：KR1020050083666
申请日：2005-09-08
Applicant: (주)아모레퍼시픽
Abstract: A cosmetic composition for suppressing sebum comprising catechins and kaempferol is provided to reduce activity of PPAR-gamma(peroxisome proliferator-activated receptor gamma) and suppress production of sebum, so that acnes symptom is alleviated. The cosmetic composition for suppressing sebum comprises catechins and kaempferol derived from green tea leaf, wherein the catechin is selected from (-)EGCG(epigallocatechin gallate), (-)GCG(gallocatechin gallate), (-)ECG(epicatechin gallate), (-)CG(catechin gallate), (-)EGC(epigallocatechin), (-)GC(gallocatechin), (-)EC(epicatechin), (+)EC(epicatechin), (-)CA(catechin) and (+)CA(catechin). The mixing ratio of catechins and kaempferol is 1:0.1-10, and the amounts of catechins and kaempferol are 0.001-30 wt.% respectively based on the total weight of the composition.
Abstract translation: 提供了用于抑制含有儿茶素和山奈酚的皮脂的化妆品组合物，以降低PPAR-γ（过氧化物酶体增殖物激活受体γ）的活性并抑制皮脂的产生，从而减轻痤疮症状。 用于抑制皮脂的化妆品组合物包括来自绿茶叶的儿茶素和山奈酚，其中儿茶素选自（ - ）EGCG（表没食子儿茶素没食子酸酯），（ - ）GCG（没食子儿茶素没食子酸酯），（ - ）ECG（表儿茶素没食子酸酯），（ - ）CG（儿茶素没食子酸酯），（ - ）EGC（儿茶素没食子酸酯），（ - ）GC（gallocatechin），（ - ）EC（表儿茶素），（+）EC ）CA（儿茶素）。 儿茶素和山奈酚的混合比为1：0.1-10，儿茶素和山奈酚的含量分别为组合物总重量的0.001-30重量％。
-
公开(公告)号：KR100692099B1
公开(公告)日：2007-03-12
申请号：KR1020060024862
申请日：2006-03-17
Applicant: (주)아모레퍼시픽
Abstract: A skin cosmetic composition is provided to inhibit activity of 3beta-hydroxysteroid dehydrogenase and metabolic pathway thereof, thereby decreasing dihydrotestosterone(DHT), which is a final metabolite and being effective for improving sebum metabolism or acne. The skin cosmetic composition for inhibiting activity of 3beta-hydroxysteroid dehydrogenase comprises 0.001-30 wt.% of at least one selected from the group consisting of epigallocatechingallate(EGCG), gallocatechingallate(GCG), quercetin, kaempferol and myricetin as an effective ingredient.
Abstract translation: 提供皮肤化妆品组合物以抑制3β-羟基类固醇脱氢酶及其代谢途径的活性，从而降低作为最终代谢物的二氢睾酮（DHT），并有效改善皮脂代谢或痤疮。 用于抑制3β-羟基类固醇脱氢酶活性的皮肤化妆品组合物包含0.001-30重量％的选自表没食子儿茶素没食子酸酯（EGCG），没食子儿茶素没食子酸酯（GCG），槲皮素，山奈酚和杨梅黄酮作为有效成分。
-
公开(公告)号：KR1020060095135A
公开(公告)日：2006-08-31
申请号：KR1020050016551
申请日：2005-02-28
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 유효성분으로 양지꽃 추출물을 함유하는 화장료 조성물에 관한 것이다. 보다 상세하게는, 본 발명의 화장료 조성물은 유효성분으로 양지꽃 추출물을 함유하여 피부에 대한 부작용 없이 안전하게 사용될 수 있을 뿐만 아니라, 세포내 항산화 방어인자 중 카탈라아제의 활성 보호능과 우수한 미백 및 보습 효과를 나타낸다.
양지꽃 * 카탈라아제 * 미백 * 보습 * 화장료-
公开(公告)号：KR1020060035140A
公开(公告)日：2006-04-26
申请号：KR1020040084495
申请日：2004-10-21
Applicant: (주)아모레퍼시픽
IPC: A61K36/28 , A61K36/9064 , A61K36/232 , A61P17/00
Abstract: 본 발명은 소자
(Perillae Semen), 우방자
(Arctii Semen) 및 초두구
(Alpiniae Katsumadaii Semen) 로 이루어진 군에서 선택된 1종 이상; 및 당귀
(Angelicae Gigantis Radix) 및 부평초
(Spirodelae Herba) 추출물로 이루어진 군에서 선택된 1종 이상의 식물 추출물을 함유하는 피부 외용제 조성물로서, IgE 매개성 알러지 반응 억제 능력에 의해 아토피성 피부염, 접촉성 피부염, 건선 등의 피부질환을 치료 또는 예방하기 위해 사용될 수 있다.
소자, 우방자, 초두구, 당귀, 부평초, 면역반응 억제, 아토피성 피부염, 접촉성 피부염, 건선-
公开(公告)号：KR1020050047233A
公开(公告)日：2005-05-20
申请号：KR1020030081033
申请日：2003-11-17
Applicant: (주)아모레퍼시픽
IPC: A61K36/9064 , A61P5/06
CPC classification number: A61K8/97 , A23L33/105 , A23V2002/00 , A23V2250/21 , A61Q19/00 , A61Q19/08
Abstract: 본 발명은 인슐린 유사 성장인자-1(Insulin-like Growth Factor-1; IGF-1)의 생체내 분비를 촉진하는 조성물에 관한 것이다. 보다 상세하게는 생약재인 사인(Amomi Semen)으로부터 추출된 사인추출물을 함유하여 IGF-1의 생체내 분비를 촉진하는 피부 외용제 및 건강보조식품에 관한 것이다. 본 발명을 통해 얻어지는 조성물은 식품 생약재로 알려진 사인추출물을 유효성분으로 함유하고 있으므로, 인체에 안전성을 가지며, 피부노화와 관련된 여러 인자들을 증진 혹은 억제하여 피부 두께 강화, 주름 개선, 및 탄력 개선 효과를 나타내어 궁극적으로 피부 노화를 지연시킬 수 있고 부작용이 없는 조성물을 제공할 수 있다.
-
-
-
-
-
-
-
-
-
Search Results
80
records
(took 0.037 seconds)
